Your session is about to expire
← Back to Search
Internet-Based Intervention for Young Breast Cancer Survivors (YES Trial)
YES Trial Summary
This trial is testing whether a web-based portal called YES can help manage symptoms in young breast cancer survivors better than standard therapy. The portal helps monitor symptoms and provides useful information and resources.
YES Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowYES Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.YES Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My breast cancer has spread to other parts of my body.I am mentally capable of following the study's procedures.I am willing to share my contact details and receive messages from the study team.I was diagnosed with stage 0-III breast cancer between ages 15-39.My breast cancer has not come back or spread.Pregnant people can participate in this study because it's important to consider fertility and pregnancy for young adult cancer survivors.I have not had any other cancer types since my breast cancer diagnosis, except for non-melanoma skin cancer.I am either younger than 15 or older than 42.I am female.I was diagnosed with breast cancer within the last 3 years.I am a young woman with breast cancer.
- Group 1: Group A (YES portal)
- Group 2: Group B (usual care)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
To whom is enrollment in this trial open?
"This research seeks 360 adolescent and young adult (AYA) women between the ages of 15-39 with a history of stage 0-III breast cancer. Eligible participants must be able to provide contact information, possess sound cognitive abilities, access medical records, have no record of other malignancies since their diagnosis excluding non-melanoma skin cancer, not be pregnant at time of enrollment in study if applicable."
Is recruitment currently underway for this experiment?
"Affirmative. The information hosted on clinicaltrials.gov indicates that this study is recruiting participants, with the first post dated June 28th 2021 and last edit October 27th 2022. A total of 360 patients need to be enrolled across 3 locations."
How many participants is the clinical trial currently accepting?
"Affirmative. Clinicaltrials.gov's information affirms that this research initiative, which was first advertised on June 28th 2021, is actively looking for participants. Approximately 360 patients must be recruited from 3 distinct clinical locations."
Does this research include participants aged 45 or older?
"According to the eligibility requirements, this medical study seeks patients aged between 15 and 39. In comparison, there are 64 trials targeting minors while 2,209 clinical studies are open for enrolment from those over 65 years old."
Share this study with friends
Copy Link
Messenger